Gilead Sciences, Inc. | GILD

Healthcare•$158.20B
Article

Will Breyanzi's Label Expansion Boost BMY's CAR T Cell Therapy Sales?

Sentiment:4
View Original
Yahoo Finance•Dec 05, 2025•18:25
Earnings ReportExpert OpinionSector Analysis
Article

Insider Activity Update: Jeffrey Bluestone Executes Options Exercise, Resulting In $296K At Gilead Sciences

Sentiment:5
View Original
Benzinga•Dec 02, 2025•15:01
Breaking News/EventEarnings ReportExpert Opinion
Article

Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today

Sentiment:0
View Original
Benzinga•Nov 28, 2025•21:45